The Director of ''AGAR In Silico Drug Design Center'' Soykan Agar, has a vast background in academic teaching, research titles and firm-wise executive managerial positions.
He earned many academic positions and grants in Netherlands, Canada and Türkiye, received many honors and awards. He enthusiastically enjoys being involved in plethora of setting from the fields including but not limited to pharmacy, chemistry, neurobiology, bio/genetic engineering and computational drug design.
We have a good workforce, over 30 research assistants, to test any ligand of interest (drug candidate molecule) for any kind of receptor (target molecule).
​
Utilizing the most updated in silico software including molecular docking, molecular dynamics and post-MD analyses software, our in silico center produces results that confirm many new drug candidate molecules, crucial in the inhibition of cancer, inflammatory, neurological and neurodegenerative diseases.
​
With our international collaborations, in vitro and in vivo confirmations for the precise genetic and protein machinery suppressions.
Soykan Agar explained the updates of his studies to Ihlas Agency News as the following: ''Within our in silico de novo drug design & repurposing group using a supercomputer infrastructure in the faculty of pharmacy at Kocaeli Health and Technology University, we design new oncological and neuro-oncological drugs and test their drug indication capabilities. We have collaborations world-wide and apply in silico, in vitro and in vivo approach to drug candidates.
Our center within the Faculty of Pharmacy follows European COST Action programs in oncological drug design and hence many collaborative studies such as EACR (European Association for Cancer Research) world-wide enhanced the network of the center.
​
AI integrated computational drug design along with ADMET estimations make our center a unique in its sector.
​
​
​
My assistants come from inter-disciplinary fields of pharmacy, genetics, chemistry and software programming.
​
Using the latest in silico tools to decipher new chemical structures and their indications towards the suppression of diseases with hardworking, unique assistants is a gift for this research center.
​
​
Thus, using the organic and inorganic chemistry, biochemistry, genetic engineering, pharmaceutical engineering and computational chemical-biology background of the members combined with the supercomputers of this center and Istanbul Technical University collaboration, we are able to work at any level of molecule and drug candidate design.
​
​Especially investigating the anti-inflammatory and antineoplastic features of new molecule candidates are crucial for our center as well as discovering new potentials in neurodegenerative diseases.
For the publications, and/or further info, please check out the following links:
​